Sp1101

CLINICAL TRIAL DESIGN FOR EARLY DETECTION INITIATIVES: TRANSLATING TOOLS INTO CLINICAL PRACTICE

Date
May 21, 2024

Presenter

Speaker Image for Suresh Chari

Tracks

Related Products

Thumbnail for CASE PRESENTATIONS
Thumbnail for A PROSPECTIVE, MULTI-INSTITUTIONAL STUDY REVEALS THE COMBINATION OF RNA ANALYSIS WITH DNA-BASED NEXT-GENERATION SEQUENCING (NGS) IMPROVES THE PREOPERATIVE CLASSIFICATION OF PANCREATIC CYSTS AND IDENTIFICATION OF ADVANCED NEOPLASIA
A PROSPECTIVE, MULTI-INSTITUTIONAL STUDY REVEALS THE COMBINATION OF RNA ANALYSIS WITH DNA-BASED NEXT-GENERATION SEQUENCING (NGS) IMPROVES THE PREOPERATIVE CLASSIFICATION OF PANCREATIC CYSTS AND IDENTIFICATION OF ADVANCED NEOPLASIA
BACKGROUND: As outlined by the Kyoto guidelines, targeted DNA-based NGS of pancreatic cyst fluid (PCF) is an important adjunct to the evaluation of pancreatic cyst patients…
Thumbnail for WEIGHT INCLUSIVITY: A HEALTH SYSTEMS APPROACH
Thumbnail for THE REGARD STUDY: A PROSPECTIVE STUDY OF RISK OF PANCREATIC DUCTAL ADENOCARCINOMA IN GLYCEMICALLY DEFINED NEW-ONSET DIABETES ASCERTAINED BY ALGORITHM BASED PASSIVE SURVEILLANCE OF ELECTRONIC HEALTH RECORDS
THE REGARD STUDY: A PROSPECTIVE STUDY OF RISK OF PANCREATIC DUCTAL ADENOCARCINOMA IN GLYCEMICALLY DEFINED NEW-ONSET DIABETES ASCERTAINED BY ALGORITHM BASED PASSIVE SURVEILLANCE OF ELECTRONIC HEALTH RECORDS
BACKGROUND: Earlier detection of pancreatic ductal adenocarcinoma (PDAC) with clinically meaningful lead time (>4 months) can improve survival…